Perry Maxwell

2.2k citations

63 papers · 1.6k indexed · h-index 24

Impact in

Health Informatics top 5%
Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Oncology 27
- Colorectal Cancer Treatments and Studies 5
Molecular Biology 21
- Molecular Biology Techniques and Applications 6

Co-authors: Manuel Salto‐Tellez (26 shared papers)Peter Hamilton (7 shared papers)Jacqueline A. James (15 shared papers)Matthew P. Humphries (3 shared papers)Peter W. Hamilton (9 shared papers)Stephen McQuaid (9 shared papers)Joe M. O’Sullivan (2 shared papers)David Waugh (3 shared papers)
Journals: Oncotarget (4 papers)Histopathology (3 papers)The Journal of Pathology (3 papers)Journal of Clinical Pathology (3 papers)British Journal of Cancer (3 papers)
Partner nations: United Kingdom Canada Ireland

In The Last Decade

Perry Maxwell

61 papers receiving 1.6k citations

Peers

Countries citing papers authored by Perry Maxwell

Since Specialization

Citations

This map shows the geographic impact of Perry Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Maxwell more than expected).

Fields of papers citing papers by Perry Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Maxwell. The network helps show where Perry Maxwell may publish in the future.

Co-authors

The 25 scholars most cited alongside Perry Maxwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Perry Maxwell Line = papers co-authored together Perry Maxwell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation Carcinogenesis ·Angela Seaton, P. Scullin, Perry Maxwell, C. M. Wilson, J Pettigrew, Ryan S. Gallagher, Joe M. O’Sullivan, Patrick G. Johnston, David Waugh	2008	118
2	Artificial intelligence—the third revolution in pathology Histopathology ·Manuel Salto‐Tellez, Perry Maxwell, Peter Hamilton	2018	108
3	Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival Cancer Research ·Asima Mukhopadhyay, Elizabeth Ruth Plummer, Ahmed Elattar, San Soohoo, Bisha Fathamah Uzir, Jennifer E. Quinn, W. Glenn McCluggage, Perry Maxwell, Harriet Aneke, Nicola J. Curtin, Richard J. Edmondson	2012	95
4	Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis PLoS ONE ·Clare McCourt, Darragh G. McArt, Ken Mills, Mark Catherwood, Perry Maxwell, David Waugh, Peter Hamilton, Joe M. O’Sullivan, Manuel Salto‐Tellez	2013	85
5	Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia British Journal of Cancer ·CM Gleeson, JM Sloan, DT McManus, Perry Maxwell, Ken Arthur, JA McGuigan, A J Ritchie, SEH Russell	1998	80
6	Erythropoietin Receptor Expression in Non-Small Cell Lung Carcinoma: A Question of Antibody Specificity Stem Cells ·W. Mark Brown, Perry Maxwell, Alastair N.J. Graham, Anita Yakkundi, Elaine A. Dunlop, Zhanzhong Shi, Patrick G. Johnston, Terence R.J. Lappin	2006	77
7	QuPath: The global impact of an open source digital pathology system Computational and Structural Biotechnology Journal ·Matthew P. Humphries, Perry Maxwell, Manuel Salto‐Tellez	2021	67
8	Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma British Journal of Urology ·M.A. Mohamed, Philipp A. Greif, James J. Diamond, Osama Sharaf, Perry Maxwell, Rodolfo Montironi, Robert A.M. Young, Peter W. Hamilton	2007	54
9	Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series Histopathology ·Maurice B. Loughrey, Jason McGrath, Helen G. Coleman, Peter Bankhead, Perry Maxwell, Claire McGready, Victoria Bingham, Matthew P. Humphries, Stephanie G. Craig, Stephen McQuaid, Manuel Salto‐Tellez, Jacqueline A. James	2020	53
10	BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer Gynecologic Oncology ·Judith Carser, Jennifer E. Quinn, Caroline O. Michie, Eamonn O’Brien, W. Glenn McCluggage, Perry Maxwell, E Lamers, T F Lioe, Alistair Williams, Richard D. Kennedy, Charlie Gourley, D. Paul Harkin	2011	52
11	Identification and overexpression of human neutrophil α-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue Oral Oncology ·Fionnuala T. Lundy, David F. Orr, James Gallagher, Perry Maxwell, Chris Shaw, Séamus S. Napier, Clarissa Cowan, Philip‐John Lamey, John Marley	2003	52
12	Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities Journal of Thoracic Oncology ·Matthew P. Humphries, Stephen McQuaid, Stephanie G. Craig, Victoria Bingham, Perry Maxwell, Manisha Maurya, Fiona McLean, James Sampson, Patricia A. Higgins, Christine Greene, Jacqueline A. James, Manuel Salto‐Tellez	2018	47
13	External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results Cytopathology ·Irena Srebotnik Kirbiš, Perry Maxwell, Margareta Strojan Fležar, Keith Miller, Mostafa Ibrahim	2011	42
14	THE EFFECT OF ANTISENSE BCL-2 OLIGONUCLEOTIDES ON BCL-2 PROTEIN EXPRESSION AND APOPTOSIS IN HUMAN BLADDER TRANSITIONAL CELL CARCINOMA The Journal of Urology ·Brian Duggan, Perry Maxwell, John D. Kelly, Paul Canning, Neil H. Anderson, Patrick F. Keane, Samuel Johnston, Kate E. Williamson	2001	41
15	Automated tumor analysis for molecular profiling in lung cancer Oncotarget ·Peter W. Hamilton, Yinhai Wang, Clinton Boyd, Jacqueline A. James, Maurice B. Loughrey, Joseph P. Hougton, David P. Boyle, Paul Kelly, Perry Maxwell, David McCleary, James J. Diamond, Darragh G. McArt, Jonathon Tunstall, Peter Bankhead, Manuel Salto‐Tellez	2015	41
16	Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment Scientific Reports ·Niamh E. Buckley, Claire Forde, Darragh G. McArt, David P. Boyle, Paul B. Mullan, Jacqueline A. James, Perry Maxwell, Stephen McQuaid, Manuel Salto‐Tellez	2016	38
17	Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies British Journal of Cancer ·Muhammad A. Alvi, Maurice B. Loughrey, Philip D. Dunne, Stephen McQuaid, Richard Turkington, Marc-Aurel Fuchs, Claire McGready, Victoria Bingham, Brendan Pang, Wendy Moore, Perry Maxwell, Mark Lawler, Jacqueline A. James, Graeme I. Murray, Richard H. Wilson, Manuel Salto‐Tellez	2017	37
18	Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility Oncotarget ·Muhammad A. Alvi, Darragh G. McArt, Paul Kelly, Marc-Aurel Fuchs, Matthew Alderdice, Clare M. McCabe, Victoria Bingham, Claire McGready, Shailesh Tripathi, Frank Emmert‐Streib, Maurice B. Loughrey, Stephen McQuaid, Perry Maxwell, Peter W. Hamilton, Richard Turkington, Jacqueline A. James, Richard H. Wilson, Manuel Salto‐Tellez	2015	35
19	Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival The Journal of Pathology ·Mohamed A. Elkablawy, Perry Maxwell, Kate E. Williamson, Neil Anderson, Peter W. Hamilton	2001	28
20	Erythropoietin drives breast cancer progression by activation of its receptor EPOR Oncotarget ·Ka Kui Chan, Kyle B. Matchett, Jonathan A. Coulter, Hiu‐Fung Yuen, Cian M. McCrudden, Shudong Zhang, Gareth Irwin, Matthew Davidson, Thomas Rülicke, Sophie Schober, Ludger Hengst, Heidelinde Jaekel, Angela Platt‐Higgins, Philip S. Rudland, Ken Mills, Perry Maxwell, Mohamed El‐Tanani, Terence R.J. Lappin	2017	28

About Perry Maxwell

Perry Maxwell is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), AI in cancer detection (10 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), Molecular Biology Techniques and Applications (6 papers), Lung Cancer Treatments and Mutations (6 papers), Genetic factors in colorectal cancer (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Health Informatics (41 citations), Oncology (676 citations), Cancer Research (360 citations), Reproductive Medicine (130 citations) and Pathology and Forensic Medicine (223 citations). Perry Maxwell has collaborated with scholars based in United Kingdom, Canada and Ireland. Frequent co-authors include Manuel Salto‐Tellez, Peter Hamilton, Jacqueline A. James, Matthew P. Humphries, Peter W. Hamilton, Stephen McQuaid, Joe M. O’Sullivan, David Waugh, Patrick G. Johnston and Darragh G. McArt. Their work appears in journals such as Oncotarget, Histopathology, The Journal of Pathology, Journal of Clinical Pathology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact